Shunya Takizawa Selected Research

Hemorrhage

1/2016	Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
9/2015	Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial.
5/2010	A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shunya Takizawa Research Topics

Disease

29	Ischemic Stroke 01/2022 - 08/2007
23	Stroke (Strokes) 01/2022 - 08/2003
10	Atrial Fibrillation 01/2020 - 08/2015
10	Infarction (Infarctions) 01/2019 - 01/2002
9	Ischemia 01/2016 - 07/2003
7	Hypoxia (Hypoxemia) 12/2013 - 08/2002
7	Cerebral Infarction 06/2013 - 11/2003
6	Brain Ischemia (Cerebral Ischemia) 07/2012 - 01/2002
4	Embolism (Embolus) 01/2020 - 01/2016
4	Transient Ischemic Attack 01/2019 - 08/2015
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 08/2015
3	Schizophrenia (Dementia Praecox) 01/2021 - 01/2021
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2020 - 10/2016
3	Migraine Disorders (Migraine) 01/2018 - 05/2009
3	Brain Injuries (Brain Injury) 04/2017 - 01/2002
3	Muscle Weakness 01/2017 - 01/2014
3	Hemorrhage 01/2016 - 05/2010
2	Infections 11/2021 - 01/2018
2	Cerebellar Ataxia (Dysmetria) 06/2021 - 01/2017
2	Moyamoya Disease (Moya-Moya Disease) 02/2020 - 11/2019
2	Brain Infarction 02/2019 - 10/2009
2	Embolic Stroke 02/2019 - 09/2018
2	Tension-Type Headache (Tension Headache) 01/2018 - 10/2017
2	Headache (Headaches) 11/2017 - 10/2017
2	Type 2 Diabetes Mellitus (MODY) 04/2017 - 04/2008
2	Hypertension (High Blood Pressure) 02/2016 - 04/2008
2	Hemorrhagic Stroke 12/2015 - 09/2015
2	Obesity 12/2015 - 04/2008
2	Thrombosis (Thrombus) 05/2010 - 04/2008
2	Fibrosis (Cirrhosis) 04/2008 - 02/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2008 - 08/2003
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2007 - 07/2003
1	Cognitive Dysfunction 01/2021
1	Hematoma 01/2020
1	Rupture 01/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2020
1	Acute Coronary Syndrome 01/2020
1	Peripheral Arterial Disease 01/2020
1	Venous Thromboembolism 01/2020
1	Vascular Malformations 11/2019
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 02/2019
1	Pathologic Constriction (Stenosis) 02/2019
1	Multiple Sclerosis 01/2019

Drug/Important Bio-Agent (IBA)

7	AnticoagulantsIBA 01/2020 - 08/2015
6	Warfarin (Coumadin)FDA LinkGeneric 07/2019 - 08/2015
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2016 - 02/2006
5	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 10/2007
5	CytokinesIBA 01/2014 - 11/2003
4	SteroidsIBA 11/2018 - 01/2013
4	Cilostazol (Pletal)FDA LinkGeneric 10/2018 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2008
3	Interleukin-10 (Interleukin 10)IBA 02/2020 - 08/2007
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020 - 07/2011
3	Antihypertensive Agents (Antihypertensives)IBA 10/2019 - 10/2009
3	Immunoglobulin G (IgG)IBA 11/2018 - 12/2016
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2009
3	AntibodiesIBA 01/2017 - 01/2015
3	Vitamin K FDA Link 01/2016 - 08/2015
3	Oxygen (Dioxygen)IBA 01/2012 - 02/2011
3	3-nitrotyrosineIBA 07/2003 - 01/2002
2	Advanced Glycation End ProductsIBA 01/2021 - 01/2009
2	inositol hexakisphosphate kinaseIBA 09/2020 - 04/2017
2	erucylphosphocholineIBA 11/2019 - 06/2016
2	Intravenous Immunoglobulins (IVIG)FDA Link 03/2018 - 05/2016
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 10/2006
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2013
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2017 - 01/2017
2	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 01/2015
2	Mitochondrial DNA (mtDNA)IBA 01/2017 - 01/2014
2	EnzymesIBA 12/2016 - 07/2011
2	CarbohydratesIBA 05/2016 - 01/2009
2	LipidsIBA 02/2016 - 01/2009
2	apixabanIBA 01/2016 - 09/2015
2	Dabigatran FDA Link 01/2016 - 09/2015
2	Clopidogrel (Plavix)FDA Link 12/2015 - 05/2010
2	Prolyl-Hydroxylase InhibitorsIBA 12/2013 - 12/2007
2	EdaravoneIBA 03/2011 - 02/2008
2	ferric chlorideIBA 05/2010 - 04/2008
2	1- (5- hydroxy- 3- methyl- 1- phenyl- 1H- pyrazol- 4- yl)- 6- methyl- 1,3- dihydrofuro(3,4- c)pyridine- 7- olIBA 02/2008 - 12/2007
2	Free RadicalsIBA 08/2003 - 07/2003
1	MicroRNAs (MicroRNA)IBA 01/2021
1	pentosidineIBA 01/2021
1	Glucuronic Acid (Glucuronate)IBA 01/2021
1	ozagrelIBA 10/2019
1	SodiumIBA 10/2019
1	fasudil (AT 877)IBA 10/2019
1	Phenobarbital (Luminal)FDA Link 02/2019
1	fibrin fragment D (D-dimer)IBA 02/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2019
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2019

Therapy/Procedure

15	Therapeutics 06/2021 - 10/2006
3	Secondary Prevention 01/2018 - 12/2015
2	Enteral Nutrition (Feeding, Tube) 11/2021 - 10/2018
2	Transplantation 01/2019 - 07/2012
2	Synchrotrons 01/2019 - 12/2015
2	Oral Administration 01/2012 - 12/2007
1	Length of Stay 11/2021
1	Carotid Endarterectomy 01/2020
1	Percutaneous Coronary Intervention 01/2020
1	Cell Transplantation 01/2019